The use of prostate-specific antigen kinetics to stratify risk in prostate cancer
โ Scribed by Joseph Presti
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 342 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1544-225X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Prostate-specific antigen (PSA) is a wellcharacterized human prostate-specific glycoprotein. PSA has been shown to be the most effective immunohistologic marker for prostate cancer, as well as the most useful serologic test in staging and monitoring prostate cancer and in early detection of recurren
Background. Prostate specific antigen (PSA) is useful as a tumor marker for monitoring patients with prostate cancer after definitive therapy. Limitations have been noted when PSA was used for the early detection of prostate cancer. The use of prostate specific antigen density [PSAD = PSA (ng/ml)/pr
Background. The serum kinetics of prostate-specific antigen (PSA) after radiation therapy for prostate cancer are not well characterized, and the potential prognostic significance of serum half-lives and of serum doubling times is unclear. This study was designed to address those issues. Methods. O